Oncology drug sales reps can sharpen in-office visits with doctors with specific actions. That’s according to a ZoomRx study of in-office oncology promotions across 120 brands during the past five years. The findings? New information, short visits and visual aids result in more impactful visits. For instance, visits where sales reps deliver novel data or information are considered “highly impactful” by 40% of oncologists versus just 24% when no new information is presented.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,